Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers

scientific article published on 8 August 2012

Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JACC.2012.04.043
P698PubMed publication ID22883634
P5875ResearchGate publication ID230655249

P50authorEvangelos GiannitsisQ91500736
Sebastian J BussQ106853489
Mostafa EmamiQ114512131
Christian GaluschkyQ114512133
Anthony HoQ20742599
Hugo A. KatusQ27929168
Stefan SchönlandQ47114671
Derliz MerelesQ47114678
Arnt V KristenQ89092443
Ute HegenbartQ89376735
P2093author name stringAndreas Voss
Christian Zugck
Grigorios Korosoglou
Dieter Schellberg
Stefan E Hardt
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectAL amyloidosisQ4652470
P304page(s)1067-1076
P577publication date2012-08-08
P1433published inJournal of the American College of CardiologyQ2984355
P1476titleLongitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers
P478volume60

Reverse relations

cites work (P2860)
Q64107474A Case Demonstrating the Cardio-Vascular Interaction by a New Cardio-Ankle Vascular Index During the Treatment of Concentric Hypertrophy
Q47313576AL amyloidosis: from molecular mechanisms to targeted therapies
Q58565612Added value of cardiac deformation imaging in differential diagnosis of left ventricular hypertrophy
Q35164550Age- and gender-related normal left ventricular deformation assessed by cardiovascular magnetic resonance feature tracking
Q42375446An unusual case of chronic lymphocytic leukemia, multiple myeloma and cardiac amyloidosis
Q95270576Analysis of Cardiac Amyloidosis Progression Using Model-Based Markers
Q48685609Assessment of global longitudinal strain using standardized myocardial deformation imaging: a modality independent software approach.
Q90322020Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function
Q64928002Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis.
Q39320411Cardiac Amyloidosis: Diagnosis and Treatment Strategies
Q38663987Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.
Q38528406Cardiac amyloidosis: where are we today?
Q86048444Clinical and imaging description of the Maron subtypes of hypertrophic cardiomyopathy
Q48666199Clinical applications and prognostic implications of strain and strain rate imaging
Q55411132Clinical characteristics and diagnosis of a rare case of systemic AL amyloidosis: a descriptive study.
Q41686949Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging.
Q48628498Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses
Q33817028Comparison of two-dimensional strain analysis using vendor-independent and vendor-specific software in adult and pediatric patients
Q61811866Contemporary Imaging Diagnosis of Cardiac Amyloidosis
Q55363722Does Masked Hypertension Cause Early Left Ventricular Impairment in Youth?
Q48667105Early Impairment of Cardiac Function and Asynchronization of Systemic Amyloidosis with Preserved Ejection Fraction Using Two-Dimensional Speckle Tracking Echocardiography
Q38420171Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy.
Q35930131Fast assessment of long axis strain with standard cardiovascular magnetic resonance: a validation study of a novel parameter with reference values
Q44045095Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation.
Q38417406Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.
Q41867190How to image cardiac amyloidosis
Q38970608Immunoglobulin Light Chain Systemic Amyloidosis
Q38172295Immunoglobulin light chain amyloidosis
Q41582133Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.
Q92482901Improvement of global longitudinal strain following high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with amyloid light-chain cardiac amyloidosis: a case report
Q48618538Incremental value of cardiac deformation analysis in acute myocarditis: a cardiovascular magnetic resonance imaging study
Q39921724Incremental value of global longitudinal strain in prediction of all-cause mortality in predialysis and dialysis chronic kidney disease patients
Q88645858Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis
Q48612495Insights into cardiac alterations after pre-eclampsia: an echocardiographic study
Q42737666Left ventricular long axis function assessed during cine-cardiovascular magnetic resonance is an independent predictor of adverse cardiac events
Q42737747Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
Q38394402Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging: comparison of high-resolution speckle tracking and feature tracking.
Q52659305Light Chain Amyloidosis.
Q39272596Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
Q88039405Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system
Q47753062Longitudinal measures of deformation are associated with a composite measure of contractility derived from pressure-volume loop analysis in children
Q39103973Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis
Q53066001Multiplane two-dimensional strain echocardiography for segmental analysis of right ventricular mechanics: new-RV study.
Q90230836Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis
Q33812497Myocardial Deformation in Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular Magnetic Resonance Feature Tracking
Q90667755Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis
Q39021835Myocardial strain to detect subtle left ventricular systolic dysfunction
Q48582664Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine
Q39024208New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis
Q47561519New concepts in the treatment and diagnosis of amyloidosis
Q88916922Novel Imaging Techniques for Heart Failure
Q38614967Novel strategies for the diagnosis and treatment of cardiac amyloidosis.
Q38259728Pathophysiology and treatment of cardiac amyloidosis
Q34776977Predictive value of assessing diastolic strain rate on survival in cardiac amyloidosis patients with preserved ejection fraction
Q47626451Predictors of survival stratification in patients with wild-type cardiac amyloidosis.
Q48172665Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis
Q40614377Prevalence, etiology, and clinical implications of reduced longitudinal systolic strain in renal transplant candidates
Q47643557Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation
Q38214579Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction
Q50996613Prognostic significance of semiautomatic quantification of left ventricular long axis shortening in systemic light-chain amyloidosis.
Q37662908Prognostic utility of blood pressure-adjusted global and basal systolic longitudinal strain
Q92755062Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis
Q26751196Recent advances in echocardiography: strain and strain rate imaging
Q38171831Recent advances in the diagnosis and management of cardiac amyloidosis
Q38935425Recent advances in the noninvasive strategies of cardiac amyloidosis
Q52645922Recurrent Syncope, a Clue in Amyloid Cardiomyopathy.
Q47114566Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis
Q36769403Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
Q33753528Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors.
Q90302919Relationship between cardiovascular risk factors and myocardial strain values of both ventricles in asymptomatic Asian subjects: measurement using cardiovascular magnetic resonance tissue tracking
Q47278693Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis
Q57299899Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
Q34392552Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques
Q38995468Strain Imaging Echocardiography: What Imaging Cardiologists Should Know
Q30251986Systemic amyloidosis
Q88733870The evolving landscape of nuclear imaging in cardiac amyloidosis
Q38074550The most important publications of the past year in echocardiography
Q97072625The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council
Q92918450Two-dimensional Echocardiographic Assessment of Myocardial Strain: Important Echocardiographic Parameter Readily Useful in Clinical Field
Q41872505Validation of noninvasive indices of global systolic function in patients with normal and abnormal loading conditions: a simultaneous echocardiography pressure-volume catheterization study.
Q41924604Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis.

Search more.